04/17/2025 | Press release | Distributed by Public on 04/17/2025 05:41
TABLE OF CONTENTS
|
|
|
|
Filed by the Registrant ☒
|
|
|
Filed by a Party other than the Registrant ☐
|
|
|
|
|
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material Under §240.14a-12
|
|
Hydrofarm Holdings Group, Inc.
|
(Name of Registrant as Specified In Its Charter)
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
|
|
|
|
☒
|
|
|
No fee required
|
☐
|
|
|
Fee paid previously with preliminary materials
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
Sincerely,
|
|
|
|
||
|
|
|
|
|
|
B. John Lindeman
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
TABLE OF CONTENTS
TIME:
|
11:00 a.m. ET
|
DATE:
|
June 9, 2025
|
ACCESS:
|
This year's annual meeting will be a virtual meeting via live webcast on the Internet. You will be able to attend the annual meeting, vote and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/HYFM2025and entering the 16-digit control number included in the Notice of Internet Availability of Proxy Materials (the "Notice") or proxy card that you receive. For further information about the virtual annual meeting, please see the Questions and Answers about the Meeting beginning on page 2.
|
1.
|
To elect two (2) class II directors to serve three-year terms expiring in 2028;
|
2.
|
To approve an advisory vote on compensation of our named executive officers;
|
3.
|
To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and
|
4.
|
To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
|
|
|
|
|
|
BY THE ORDER OF THE BOARD OF DIRECTORS
|
|
|
|
||
|
|
|
|
|
|
B. John Lindeman
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
PAGE
|
|
IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING
|
|
|
2
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
|
|
6
|
MANAGEMENT AND CORPORATE GOVERNANCE
|
|
|
7
|
EXECUTIVE OFFICER AND DIRECTOR COMPENSATION
|
|
|
23
|
PAY VERSUS PERFORMANCE
|
|
|
27
|
EQUITY COMPENSATION PLAN INFORMATION
|
|
|
30
|
REPORT OF AUDIT COMMITTEE
|
|
|
31
|
DELINQUENT SECTION 16(A) REPORTS
|
|
|
32
|
CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS
|
|
|
33
|
PROPOSAL NO. 1 ELECTION OF DIRECTORS
|
|
|
35
|
PROPOSAL NO. 2 ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS
|
|
|
36
|
PROPOSAL NO. 3 RATIFY SELECTION OF INDEPENDENT AUDITORS
|
|
|
37
|
CODE OF CONDUCT AND ETHICS
|
|
|
39
|
OTHER MATTERS
|
|
|
40
|
STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR
|
|
|
40
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
•
|
By Internet or by telephone. Follow the instructions included in the Notice or, if you received printed materials, in the proxy card to vote over the Internet or by telephone. Internet and telephone voting facilities for stockholders of record will be available 24 hours a day and will close at 11:59 p.m. ET on June 5, 2025.
|
•
|
By mail. If you received a proxy card by mail, you can vote by mail by completing, signing, dating and returning the proxy card as instructed on the card. If you sign the proxy card but do not specify how you want your shares voted, they will be voted in accordance with our board of directors' recommendations as noted below.
|
•
|
At the time of the virtual annual meeting. If you attend the virtual annual meeting, you may vote your shares online at the time of the meeting.
|
☐
|
"FOR" the election of each of the nominees for director;
|
☐
|
"FOR" the compensation of our named executive officers, as disclosed in this proxy statement; and
|
☐
|
"FOR" the ratification of the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.
|
☐
|
if you received a proxy card, by signing a new proxy card with a date later than your previously delivered proxy and submitting it as instructed above;
|
☐
|
by re-voting by Internet or by telephone as instructed above;
|
☐
|
by notifying Hydrofarm's Chief Financial Officer in writing before the annual meeting that you have revoked your proxy; or
|
☐
|
by attending the annual meeting and voting at the meeting. Attending the annual meeting will not in and of itself revoke a previously submitted proxy. You must specifically request at the annual meeting that it be revoked.
|
TABLE OF CONTENTS
|
|
|
|
Proposal 1: Elect Directors
|
|
|
The nominees for director who receive the most votes (also known as a "plurality" of the votes cast) will be elected. You may vote either FOR all of the nominees, WITHHOLD your vote from all of the nominees or WITHHOLD your vote from any one of the nominees. Votes that are withheld will not be included in the vote tally for the election of the directors. Brokerage firms do not have authority to vote customers' shares held by the firms in street name for which the beneficial owner has not instructed such firm how to vote for the election of the directors. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote.
|
|
|
||
Proposal 2: Consider Advisory Vote on Compensation of the Corporation's Named Executive Officers
|
|
|
The affirmative vote of a majority of the shares cast for this proposal is required to approve, on an advisory basis, the compensation of our named executive officers, as described in this proxy statement. Abstentions will have no effect on the results of this vote. Brokerage firms do not have authority to vote customers' shares held by the firms in street name for which the beneficial owner has not instructed such firm how to vote on this proposal. As a result, any shares not voted by a customer will be treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote. Although the advisory vote is non-binding, our board of directors and the compensation committee of our board of directors (the "Compensation Committee") will review the voting results and take them into consideration when making future decisions regarding executive compensation.
|
|
|
||
Proposal 3: Ratify Selection of Independent Auditor
|
|
|
The affirmative vote of a majority of the shares cast for this proposal is required to ratify the selection of our independent registered public accounting firm. Abstentions will have no effect on the results of this vote. Brokerage firms have authority to vote customers' shares held by the firms in street name for which the beneficial owner has not instructed such firm how to vote on this proposal. If a broker does not exercise this authority, such broker non-votes will have no effect on the results of this vote. We are not required to obtain the approval of our stockholders to select our independent registered public accounting firm. However, if our stockholders do not ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025, the audit committee (the "Audit Committee") of our board of directors will reconsider its selection.
|
|
|
|
|
TABLE OF CONTENTS
•
|
following the instructions provided on your Notice or proxy card;
|
•
|
following the instructions provided when you vote over the Internet; or
|
•
|
going to www.virtualshareholdermeeting.com/HYFM2025and follow the instructions provided.
|
TABLE OF CONTENTS
|
|
|
|
|||
|
|
Shares Beneficially Owned
|
||||
Name and Address of Beneficial Owner
|
|
|
Number
|
|
|
Percent
|
5%+ Stockholders:
|
|
|
|
|
||
Janusz Michal Bogaczyk(1)
|
|
|
454,000
|
|
|
9.8%
|
Persons affiliated with Dumont Global LP(2)
|
|
|
327,000
|
|
|
7.1%
|
Directors and Named Executive Officers:
|
|
|
|
|
||
William Toler(3)
|
|
|
193,772
|
|
|
4.2%
|
B. John Lindeman(4)
|
|
|
32,695
|
|
|
*
|
Mark Parker(5)
|
|
|
13,803
|
|
|
*
|
Richard D. Moss(6)
|
|
|
15,503
|
|
|
*
|
Renah Persofsky(7)
|
|
|
15,453
|
|
|
*
|
Melisa Denis(8)
|
|
|
15,373
|
|
|
*
|
Susan P. Peters(9)
|
|
|
15,303
|
|
|
*
|
Patrick Chung(10)
|
|
|
15,103
|
|
|
*
|
All directors and current executive officers as a group (10 persons)
|
|
|
325,207
|
|
|
6.9%
|
|
|
|
|
|
|
|
*
|
Represents beneficial ownership of less than 1% of the outstanding shares of our common stock.
|
(1)
|
This information is based solely on a Schedule 13G filed with the SEC by Janusz Michal Bogaczyk on March 28, 2025. The address for Mr. Bogaczyk is 3 Wisniowa Street, postal code: 62-081 Chyby, Poland.
|
(2)
|
This information is based solely on a Schedule 13G filed with the SEC by Dumont Global LP ("DG"), Dumont Fund Partners LLC ("DFP"), Dumont Master Fund LP (the "Fund") and Chris Yetter (collectively, the "Dumont Parties") on March 12, 2025. Chris Yetter is (i) the manager of Dumont Global Partners LLC, which is the general partner of DG, and (ii) the general partner of DFP. DFP is the general partner of the Fund and DG is the investment manager of the Fund. DG, in its capacity as investment manager of the Fund, has shared power with Chris Yetter to vote and dispose of the shares held by the Fund. The address for the Dumont Parties is 110 E 25th Street #215, New York, NY 10010.
|
(3)
|
Represents 183,771 shares of our common stock and 10,001 shares of common stock that will vest within 60 days of March 31, 2025.
|
(4)
|
Represents 28,736 shares of our common stock and 3,959 shares of common stock that will vest within 60 days of March 31, 2025.
|
(5)
|
Represents 6,602 shares of our common stock, 2,751 shares of common stock that will vest within 60 days of March 31, 2025 and 4,450 shares of common stock issuable upon the exercise of options.
|
(6)
|
Represents 2,914 shares of our common stock and 12,589 shares of our common stock issuable under deferred RSUs settleable by issuing shares of common stock within 60 days of March 31, 2025.
|
(7)
|
Represents 2,864 shares of our common stock and 12,589 shares of our common stock issuable under deferred RSUs settleable by issuing shares of common stock within 60 days of March 31, 2025.
|
(8)
|
Represents 2,996 shares of our common stock and 12,377 shares of our common stock issuable under deferred RSUs settleable by issuing shares of common stock within 60 days of March 31, 2025.
|
(9)
|
Represents 2,714 shares of our common stock and 12,589 shares of our common stock issuable under deferred RSUs settleable by issuing shares of common stock within 60 days of March 31, 2025.
|
(10)
|
Represents 2,726 shares of our common stock and 12,377 shares of our common stock issuable under deferred RSUs settleable by issuing shares of common stock within 60 days of March 31, 2025.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
Name
|
|
|
Age
|
|
|
Position with the Company
|
William Toler
|
|
|
65
|
|
|
Executive Chairman of the Board
|
Patrick Chung
|
|
|
35
|
|
|
Director
|
Melisa Denis
|
|
|
61
|
|
|
Director
|
Richard D. Moss
|
|
|
67
|
|
|
Director, Chairperson of Audit Committee and Mergers and Acquisitions Committee
|
Renah Persofsky
|
|
|
66
|
|
|
Director, Chairperson of Nominating Committee
|
Susan P. Peters
|
|
|
71
|
|
|
Director, Chairperson of Compensation Committee
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
•
|
evaluating and making recommendations to the full board of directors as to the composition, organization and governance of our board of directors and its committees,
|
•
|
evaluating and making recommendations as to director candidates,
|
•
|
evaluating current board members' performance,
|
•
|
overseeing the process for Chief Executive Officer and other executive officer succession planning, and
|
•
|
developing and recommending governance guidelines for the Company.
|
TABLE OF CONTENTS
•
|
As to each person who the stockholder proposes to nominate for election, all information relating to such person that would be required to be disclosed in a proxy statement or as otherwise required, in each case, pursuant to Regulation 14A under the Exchange Act;
|
•
|
certain biographical and share ownership information about the stockholder and any other proponent, including a description of any derivative transactions in the Company's securities;
|
•
|
a description of certain arrangements and understandings between the proposing stockholder and any beneficial owner and any other person in connection with such stockholder nomination; and
|
•
|
a statement whether or not either such stockholder or beneficial owner intends to deliver a proxy statement and form of proxy to holders of voting shares sufficient to carry the proposal.
|
•
|
certain biographical information concerning the proposed nominee;
|
•
|
all information concerning the proposed nominee required to be disclosed in solicitations of proxies for election of directors;
|
•
|
certain information about any other security holder of the Company who supports the proposed nominee;
|
•
|
a description of all relationships between the proposed nominee and the recommending stockholder or any beneficial owner, including any agreements or understandings regarding the nomination; and
|
•
|
additional disclosures relating to stockholder nominees for directors, including completed questionnaires and disclosures required by our Bylaws.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
Name
|
|
|
Age
|
|
|
Position
|
B. John Lindeman
|
|
|
55
|
|
|
Chief Executive Officer and Principal Executive Officer
|
Kevin O'Brien
|
|
|
45
|
|
|
Chief Financial Officer
|
Mark Parker
|
|
|
65
|
|
|
President
|
Erica Ackerman
|
|
|
50
|
|
|
Chief Accounting Officer
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
|
|
|
Name
|
|
|
Position(s)
|
William Toler
|
|
|
Chairman of the Board & Chief Executive Officer (principal executive officer)
|
B. John Lindeman
|
|
|
Executive Vice President & Chief Financial Officer
|
Mark Parker
|
|
|
Executive Vice President of Sales and Business Development
|
|
|
|
|
•
|
Base Salary: We did not increase base salaries during fiscal 2024 for our named executive officers.
|
•
|
Annual Incentive Bonus: Our annual incentive bonus was comprised of a combination of cash awards and PSUs, which align the interests of our employees with those of our stockholders.
|
•
|
Retention Awards: We granted retention awards to our named executive officers in fiscal 2023, a portion of which vested and were paid in fiscal 2024, to further align pay and performance. No additional retention awards were granted in fiscal 2024.
|
TABLE OF CONTENTS
|
|
|
|
What We Do
|
|
|
What We Do Not Do
|
✔ We focus on pay-for-performance by emphasizing
performance-based incentive opportunities.
✔ We set clear financial goals that we believe are
challenging yet achievable, meet or exceed
competitive standards and are aligned with
business objectives to enhance stockholder value
over time.
✔ We consider both long-term and short-term
incentives to align our executive officers'
performance goals with our overall performance.
✔ We use multiple performance metrics for incentive
compensation to better align incentives with
overall company performance.
✔ We benchmark our executive officers'
compensation against an appropriate peer group.
✔ We maintain stock ownership guidelines for
executive officers. ✔ We monitor our pay practices on an ongoing basis to ensure they do not encourage excessive risk
taking.
|
|
|
✘ We do not offer perquisites that are not aligned
with market practices.
✘ We do not permit executive officers or directors
to engage in hedging, pledging, or similar types of
transactions with respect to our stock.
✘ We do not permit backdating or repricing of stock options.
✘ We do not guarantee salary increases for our
executive officers.
✘ We do not use the same performance measures
for short-term and long-term incentives to ensure
our executive officers focus on both short-term
and long-term goals.
✘ We do not provide excise tax gross-ups.
|
|
|
|
|
TABLE OF CONTENTS
•
|
Annual base salary;
|
•
|
Annual incentive bonuses; and
|
•
|
Retention awards.
|
|
|
|
|
|
|
|
Executive
|
|
|
Fiscal 2024 Base Salary ($)
|
|
|
Percentage Increase in Base
Salary from Fiscal 2023
|
William Toler
|
|
|
600,000
|
|
|
0%
|
B. John Lindeman
|
|
|
475,000
|
|
|
0%
|
Mark Parker
|
|
|
330,000
|
|
|
0%
|
|
|
|
|
|
|
|
•
|
the negotiated terms of each named executive officer's employment agreement, if any;
|
•
|
an internal review of the named executive officer's compensation, both individually and relative to other named executive officers;
|
•
|
base salaries paid by comparable companies that have a similar business and financial profile; and
|
•
|
our overall financial performance.
|
TABLE OF CONTENTS
•
|
Cash Severance: a lump sum payment equal to the greater of $250,000 or six months of then-effective salary.
|
•
|
COBRA Severance: reimbursement for COBRA expenses until the earliest to occur of (i) the six-month anniversary of termination or resignation, (ii) the date of obtaining health care coverage from another source and (iii) the date on which COBRA benefits expire.
|
•
|
Accelerated Vesting: immediate and automatic vesting of all unvested RSU awards and stock options that by their terms vest over the twelve-month period following termination or resignation.
|
•
|
Accrued Amounts: payment of all accrued salary, accrued bonus, unused vacation, earned but unpaid bonus amounts and reimbursement for any unreimbursed business expenses.
|
TABLE OF CONTENTS
•
|
provide that all outstanding options shall be assumed or substituted by the successor corporation, or in the event that such outstanding options are not assumed or substituted by the successor corporation, such options shall become fully vested and exercisable or payable and all applicable restrictions or forfeiture provisions shall lapse;
|
•
|
all performance-based awards earned and outstanding shall be payable in full in accordance with the payout schedule in the award instrument; and
|
•
|
in lieu of the foregoing, all performance-based awards may also be terminated by the board of directors, in its sole discretion, and the holder shall receive a cash payment equal to the consideration payable upon consummation of such transaction to a holder of the number of shares of common stock comprising such award.
|
TABLE OF CONTENTS
•
|
provide that all outstanding options shall be assumed or substituted by the successor corporation;
|
•
|
upon written notice to a participant, provide that the participant's exercisable options may be exercised within a certain number of days and the participant's unexercised options will terminate immediately prior to the consummation of such transaction unless exercised by the participant;
|
•
|
in the event of a merger or reorganization event pursuant to which holders of our common stock will receive a cash payment for each share surrendered in the merger, make or provide for a cash payment to the participants equal to the difference between the merger price times the number of shares of our common stock subject to such outstanding options, and the aggregate exercise price of all such outstanding options, in exchange for the termination of such options;
|
•
|
provide that outstanding awards shall be assumed or substituted by the successor corporation, become realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon the merger or reorganization event; and
|
•
|
with respect to stock grants and in lieu of any of the foregoing, the board of directors or an authorized committee may provide that, upon consummation of the transaction, each outstanding stock grant shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such transaction to a holder of the number of shares of common stock comprising such award (to the extent such stock grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of our board of directors or an authorized committee, all forfeiture and repurchase rights being waived upon such transaction).
|
•
|
All unvested but exercisable options shall expire upon termination.
|
•
|
All vested and exercisable options shall expire on the earliest of (i) if termination is not for Cause (as defined in the 2018 Plan), death or disability, three months following termination, (ii) if termination is due to death or disability, one year following termination and (iii) the last day of the original term of the option.
|
•
|
If the participant dies following termination but has otherwise exercisable options, these options shall expire on the earlier of (i) the last day of the original term of the option and (ii) the one-year anniversary of the date of death.
|
•
|
If termination is for Cause, all options, regardless of vesting status, shall automatically and immediately expire and terminate.
|
•
|
If an option is otherwise exercisable but the issuance of common stock upon its exercise would violate federal or state securities laws, following termination the option will remain exercisable until the earlier of (i) the last day of the original term of the option and (ii) three months following the date when issuance no longer violates securities laws.
|
•
|
An option designated as an incentive stock option shall cease to qualify for favorable tax treatment as an incentive stock option to the extent it is exercised (i) more than three months after termination if termination was for reasons other than death or disability, (ii) more than one year after termination if termination was by reason of disability, or (iii) more than six months following the first day of a leave of absence that exceeds three months (unless reemployment rights are guaranteed).
|
TABLE OF CONTENTS
•
|
Termination not for Cause (as defined in each Incentive Plan), death or disability: Participants may continue to exercise any exercisable options until the last day of the original term of such options. However, participants who reside in California must be able to exercise options at least until the earlier of (i) 30 days following termination and (ii) the last day of the original option term. Under the 2020 Plan, no option intended to be an incentive stock option may be exercised more than three months following termination.
|
•
|
Termination for Cause: All unexercised options will be immediately forfeited.
|
•
|
Termination due to disability: All exercisable options may be exercised for one year following termination. If exercise rights accrue periodically, any vesting rights that would have accrued as of the next vesting date will be prorated as of the date of termination. However, participants who reside in California may only exercise options until the earlier of (i) six months from termination and (ii) the last day of the original option term.
|
•
|
Termination due to death: All exercisable options may be exercised by the participant's survivors for one year following death. If exercise rights accrue periodically, any vesting rights that would have accrued as of the next vesting date will be prorated as of the date of death. However, survivors of participants who resided in California may only exercise options until the earlier of (i) six months from the date of death and (ii) the last day of the original option term.
|
•
|
Termination not for Cause (as defined in each Incentive Plan), death or disability: The Company shall have the right to cancel or repurchase the number of shares subject to the participant's stock awards until the Company's forfeiture or repurchase rights lapse under the respective agreement.
|
•
|
Termination for Cause: All shares subject to a participant's stock awards that remain subject to forfeiture shall be immediately forfeited to the Company.
|
•
|
Termination due to disability: If the Company's forfeiture or repurchase rights have not lapsed, the Company may still exercise such rights. If such rights lapse periodically, they will lapse pro rata as of the date of disability.
|
•
|
Termination due to death: If the Company's forfeiture or repurchase rights have not lapsed, the Company may still exercise such rights. If such rights lapse periodically, they will lapse pro rata as of the date of death.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
Position
|
|
|
Ownership Guidelines
|
|
|
Chairman of the Board and Chief Executive Officer
|
|
|
6x base salary
|
|
|
Chief Financial Officer
|
|
|
4x base salary
|
|
|
Executive Leadership Team
|
|
|
2x base salary
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and
Principal Position
|
|
|
Year
|
|
|
Salary
($)
|
|
|
Bonus
($)
|
|
|
Stock
Awards
($)(1)
|
|
|
All other
Compensation
($)(2)
|
|
|
Total
($)
|
William Toler,
Chairman of the Board and
Chief Executive Officer
|
|
|
2024
|
|
|
600,000
|
|
|
25,875
|
|
|
300,010
|
|
|
26,090
|
|
|
951,975
|
|
2023
|
|
|
600,000
|
|
|
75,000
|
|
|
750,002
|
|
|
23,049
|
|
|
1,448,051
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
B. John Lindeman,
Executive Vice President and
Chief Financial Officer
|
|
|
2024
|
|
|
475,000
|
|
|
72,742
|
|
|
118,751
|
|
|
37,568
|
|
|
704,061
|
|
2023
|
|
|
475,000
|
|
|
217,188
|
|
|
178,126
|
|
|
33,189
|
|
|
903,503
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Mark Parker,
Executive Vice President of Sales and Business Development
|
|
|
2024
|
|
|
330,000
|
|
|
7,116
|
|
|
85,207
|
|
|
37,568
|
|
|
457,191
|
|
2023
|
|
|
330,000
|
|
|
45,625
|
|
|
185,751
|
|
|
33,189
|
|
|
594,565
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts reported in the "Stock Awards" column represent grant date fair value of the RSUs and PSUs granted to the named executive officers during the fiscal years ended December 31, 2024 and 2023 as computed in accordance with ASC 718. Note that the amounts reported in this column reflect the accounting cost for these stock awards and do not correspond to the actual economic value that may be received by the named executive officers from the stock awards. Assumptions used in the calculation of these amounts are included in Note 2 and Note 12 to the Consolidated Financial Statements in our Annual Report on Form 10-K. The maximum aggregate grant date value of the PSUs awarded in 2024, assuming that the highest level of performance conditions would have been achieved, was as follows: Mr. Toler - $300,010, Mr. Lindeman - $118,751 and Mr. Parker - $85,207.
|
(2)
|
"All Other Compensation" consists of health insurance premiums.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
||||||||||||||||||
|
|
Option Awards
|
|
|
Stock Awards
|
|||||||||||||||||||
Name and Principal
Position
|
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
|
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
|
|
|
Option
Exercise
Price
($)
|
|
|
Option
Expiration
Date
|
|
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)
|
|
|
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)(1)
|
|
|
Equity
incentive
plan awards:
Number of
unearned
shares, units,
or other
rights that
have not
vested
(#)
|
|
|
Equity
incentive plan
awards:
Market or
payout value
of unearned
shares, units
or other
rights that
have not
vested
($)
|
William Toler,
Chairman of the Board and Chief Executive Officer
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
30,304(2)
|
|
|
175,763(2)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,500(3)
|
|
|
8,700(3)
|
|
|
-
|
|
|
-
|
||
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
667(4)
|
|
|
3,869(4)
|
|
|
-
|
|
|
-
|
||
B. John Lindeman,
Executive Vice President and Chief Financial Officer
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
11,995(5)
|
|
|
69,571(5)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1,167(6)
|
|
|
6,769(6)
|
|
|
-
|
|
|
-
|
||
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
334(7)
|
|
|
1,937(7)
|
|
|
-
|
|
|
-
|
||
Mark Parker,
Executive Vice President of Sales and Business Development
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
8,334(8)
|
|
|
48,337(8)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
3,334(9)
|
|
|
19,337(9)
|
|
|
-
|
|
|
-
|
||
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
834(10)
|
|
|
4,837(10)
|
|
|
-
|
|
|
-
|
||
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
167(11)
|
|
|
969(11)
|
|
|
-
|
|
|
-
|
||
|
3,968(12)
|
|
|
-
|
|
|
$84.28
|
|
|
6/10/2029
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
||
|
482(13)
|
|
|
-
|
|
|
$84.28
|
|
|
6/10/2029
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the fair market value of shares that were unvested as of December 31, 2024. The fair market value is based on the closing price on December 31, 2024, the last trading day of 2024, of $5.80 per share.
|
(2)
|
Mr. Toler was granted 30,304 PSUs on April 5, 2024, vesting, to the extent they are determined to have been earned based on the relevant performance metrics, in a single installment on April 5, 2025. The board of directors determined that 10,001 shares subject to this award had been earned based on the relevant performance metrics and such shares vested on April 5, 2025.
|
(3)
|
Mr. Toler was granted 4,500 RSUs on August 17, 2022, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
(4)
|
Mr. Toler was granted 2,000 RSUs on March 23, 2022, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
(5)
|
Mr. Lindeman was granted 11,995 PSUs on April 5, 2024, vesting, to the extent they are determined to have been earned based on the relevant performance metrics, in a single installment on April 5, 2025. The board of directors determined that 3,959 shares subject to this award had been earned based on the relevant performance metrics and such shares vested on April 5, 2025.
|
(6)
|
Mr. Lindeman was granted 3,500 RSUs on August 17, 2022, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
(7)
|
Mr. Lindeman was granted 1,000 RSUs on February 25, 2022, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
TABLE OF CONTENTS
(8)
|
Mr. Parker was granted 8,334 PSUs on April 5, 2024, vesting, to the extent they are determined to have been earned based on the relevant performance metrics, in a single installment on April 5, 2025. The board of directors determined that 2,751 shares subject to this award had been earned based on the relevant performance metrics and such shares vested on April 5, 2025.
|
(9)
|
Mr. Parker was granted 5,000 RSUs on August 8, 2023, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
(10)
|
Mr. Parker was granted 2,500 RSUs on August 17, 2022, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
(11)
|
Mr. Parker was granted 500 RSUs on February 25, 2022, vesting in three equal annual installments beginning on the first anniversary of the grant date.
|
(12)
|
Mr. Parker was granted 3,968 incentive stock options on June 10, 2019, of which 25% vested on June 10, 2020 and the remaining 75% vested in 36 equal monthly installments.
|
(13)
|
Mr. Parker was granted 482 non-qualified stock options on June 10, 2019, of which 25% vested on June 10, 2020 and the remaining 75% vested in 36 equal monthly installments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
|
Fees
Earned or
Paid in
Cash
($)
|
|
|
Stock
Awards(1)
($)
|
|
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
|
|
Total
($)
|
Patrick Chung
|
|
|
75,000
|
|
|
125,001
|
|
|
-
|
|
|
200,001
|
Melisa Denis
|
|
|
75,000
|
|
|
125,001
|
|
|
-
|
|
|
200,001
|
Richard D. Moss(2)
|
|
|
100,000
|
|
|
125,001
|
|
|
-
|
|
|
225,501
|
Renah Persofsky
|
|
|
85,000
|
|
|
125,001
|
|
|
-
|
|
|
210,001
|
Susan P. Peters
|
|
|
90,000
|
|
|
125,001
|
|
|
-
|
|
|
215,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
These amounts represent the aggregate grant date fair value of the stock awards granted to each director during the fiscal year ended December 31, 2024, computed in accordance with ASC 718. We granted 16,047 RSUs as annual equity awards to each of our non-employee directors. Such awards vest on June 6, 2025.
|
(2)
|
On February 28, 2025, Mr. Moss tendered his resignation from the Company's board of directors to be effective as of immediately prior to the annual meeting, which was accepted by our board of directors.
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
|
Summary
Compensation
Table Total for
PEO(1)
|
|
|
Compensation
Actually Paid to
PEO(2)
|
|
|
Average
Summary
Compensation
Table Total for
Non-PEO NEOs(3)
|
|
|
Average
Compensation
Actually Paid to
Non-PEO NEOs(4)
|
|
|
Value of Initial
Fixed $100
Investment Based
On Total
Shareholder
Return(5)
|
|
|
Net
(Loss)
Income (in
millions)(6)
|
2024
|
|
|
$951,975
|
|
|
$677,287
|
|
|
$580,626
|
|
|
$482,376
|
|
|
$2.05
|
|
|
($66.717)
|
2023
|
|
|
$1,448,051
|
|
|
$798,228
|
|
|
$749,034
|
|
|
$549,522
|
|
|
$3.24
|
|
|
($64.813)
|
2022
|
|
|
$3,085,722
|
|
|
($9,499,962)
|
|
|
$1,330,842
|
|
|
($2,292,004)
|
|
|
$5.48
|
|
|
($285.415)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Mr. Toler was our PEO for each of 2024, 2023, and 2022. The dollar amounts reported in this column are the amounts of total compensation reported for Mr. Toler for each corresponding year in the "Total" column of the Summary Compensation Table. The Summary Compensation Table for the years ended December 31, 2024 and 2023 can be found under "Executive Officer and Director Compensation" above. The Summary Compensation Table for the year ended December 31, 2022 can be found in our proxy statement filed with the SEC on April 17, 2024.
|
(2)
|
The dollar amounts reported in this column represent the CAP to Mr. Toler, as computed in accordance with SEC rules. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. Toler during the applicable year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
|
Reported Summary
Compensation Table Total
for PEO
|
|
|
Reported Value of
Equity Awards(i)
|
|
|
Equity Award
Adjustments(ii)
|
|
|
Compensation
Actually Paid to PEO
|
2024
|
|
|
$951,975
|
|
|
($300,010)
|
|
|
$25,322
|
|
|
$677,287
|
2023
|
|
|
$1,448,051
|
|
|
($750,002)
|
|
|
$100,179
|
|
|
$798,228
|
2022
|
|
|
$3,085,722
|
|
|
($2,373,561)
|
|
|
($10,212,123)
|
|
|
($9,499,962)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
The grant date fair value of equity awards in this column represents the total of the amounts reported in the "Stock Awards" and "Option Awards" columns in the Summary Compensation Table for the applicable year.
|
(ii)
|
The equity award adjustments in this column include the addition (or subtraction, as applicable) of the following: (1) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (2) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (3) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (4) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (5) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (6) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
|
Year
End Fair
Value of
Equity
Awards
Outstanding
and
Unvested as
of Year End
|
|
|
Change
in Fair Value
of Prior Year
Equity
Awards
Outstanding
and Unvested
as of Year
End
|
|
|
Fair
Value as
of
Vesting
Date of
Equity
Awards
Granted
and
Vested
in
the Year
|
|
|
Change in
Fair Value
as of
Vesting
Date
of Equity
Awards
Granted in
Prior Years
that Vested
in the Year
|
|
|
Fair
Value
at the
End of
the
Prior
Year of
Equity
Awards
that
Failed
to Meet
Vesting
Conditions
in the
Year
|
|
|
Value of
Dividends or
Other
Earnings
Paid on Stock
or Option
Awards in the
Year not
Otherwise
Included in
Total
Compensation
|
|
|
Total
Equity
Award
Adjustments
|
2024
|
|
|
$58,006
|
|
|
($7,314)
|
|
|
$0
|
|
|
($25,370)
|
|
|
($0)
|
|
|
$0
|
|
|
$25,322
|
2023
|
|
|
$119,792
|
|
|
($47,502)
|
|
|
$86,566
|
|
|
($33,197)
|
|
|
($25,480)
|
|
|
$0
|
|
|
$100,179
|
2022
|
|
|
$207,720
|
|
|
($4,494,860)
|
|
|
$499,997
|
|
|
($6,424,980)
|
|
|
$0
|
|
|
$0
|
|
|
($10,212,123)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
(3)
|
The dollar amounts reported this column represent the average of the amounts reported for the Company's non-PEO NEOs in the "Total" column of the Summary Compensation Table in each applicable year. The names of each of the non-PEO NEOs included for purposes of calculating the average amounts in each applicable year are B. John Lindeman and Mark Parker.
|
(4)
|
The dollar amounts reported in this column represent the average amount of CAP to the non-PEO NEOs, as computed in accordance with SEC rules. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr. Toler) during the applicable year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
|
Average Reported Summary
Compensation Table Total
for Non-PEO NEOs
|
|
|
Average Reported
Value of Equity
Awards
|
|
|
Average Equity
Award
Adjustments(i)
|
|
|
Average Compensation
Actually Paid to Non-
PEO NEOs
|
2024
|
|
|
$580,626
|
|
|
($100,629)
|
|
|
$2,379
|
|
|
$482,376
|
2023
|
|
|
$749,034
|
|
|
($181,939)
|
|
|
($17,573)
|
|
|
$549,522
|
2022
|
|
|
$1,330,842
|
|
|
($870,411)
|
|
|
($2,752,435)
|
|
|
($2,292,004)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
The amounts deducted or added in calculating the total average equity award adjustments are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year
|
|
|
Average
Year
End
Fair
Value of
Equity
Awards
Outstanding
and
Unvested as
of Year End
|
|
|
Average
Change in
Fair Value
of Prior
Year
Equity
Awards
Outstanding
and
Unvested as
of Year End
|
|
|
Average
Fair
Value as
of
Vesting
Date of
Equity
Awards
Granted
and
Vested
in the
Year
|
|
|
Average
Change in
Fair Value
as of
Vesting
Date
of Equity
Awards
Granted in
Prior Years
that Vested
in the Year
|
|
|
Average
Fair Value
at the End
of the
Prior
Year of
Equity
Awards
that
Failed
to Meet
Vesting
Conditions
in the
Year
|
|
|
Average
Value of
Dividends or
Other
Earnings
Paid on Stock
or Option
Awards in the
Year not
Otherwise
Included in
Total
Compensation
|
|
|
Total
Equity
Award
Adjustments
|
2024
|
|
|
$19,459
|
|
|
($9,848)
|
|
|
$0
|
|
|
($7,232)
|
|
|
$0
|
|
|
$0
|
|
|
$2,379
|
2023
|
|
|
$36,435
|
|
|
($30,928)
|
|
|
$0
|
|
|
($14,533)
|
|
|
($8,547)
|
|
|
$0
|
|
|
($17,573)
|
2022
|
|
|
$91,298
|
|
|
($1,844,693)
|
|
|
$153,953
|
|
|
($1,152,993)
|
|
|
$0
|
|
|
$0
|
|
|
($2,752,435)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5)
|
The cumulative total shareholder return ("TSR") amounts reported in this column are calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company's share price at the end and the beginning of the measurement period by the Company's share price at the beginning of the measurement period.
|
(6)
|
The dollar amounts reported this column are the Company's net income amounts reflected in the Company's audited financial statements for the applicable year.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
Plan category
|
|
|
Number of
securities to
be
issuable
upon
exercise of
outstanding
options,
warrants
and rights(1)
|
|
|
Weighted-
average
exercise
price of
outstanding
options,
warrants
and
rights(2)
|
|
|
Number of
securities
remaining
available
for future
issuance
under equity
compensation
plans
(excluding
securities
reflected
in column
(a))(3)
|
Equity compensation plans approved by security holders(4)
|
|
|
268,467
|
|
|
$96.36
|
|
|
213,551
|
Equity compensation plans not approved by security holders
|
|
|
-
|
|
|
-
|
|
|
-
|
Total
|
|
|
268,467
|
|
|
$96.36
|
|
|
213,551
|
|
|
|
|
|
|
|
|
|
|
(1)
|
These plans consist of the 2020 Plan, the 2019 Plan and the 2018 Plan. For a description of these plans, see Note 12 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K.
|
(2)
|
The weighted-average exercise price excludes any outstanding stock awards, which have no exercise price.
|
(3)
|
Consists only of securities remaining available for future issuance under the 2020 Plan. Since our 2020 Plan has been approved by our stockholders, we do not intend to make any additional grants under the 2018 Plan and the 2019 Plan.
|
(4)
|
The 2020 Plan provides that the total number of shares of our common stock reserved for issuance thereunder will automatically increase on January 1st of each year for a period of ten years commencing on January 1, 2021 and ending on January 2, 2030, in an amount equal to the lesser of (i) 4% of the outstanding shares of our common stock on such date and (ii) such number of shares determined by the plan administrator.
|
TABLE OF CONTENTS
•
|
Reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2024 with management and Deloitte & Touche LLP, our independent registered public accounting firm;
|
•
|
Discussed with Deloitte & Touche LLP the matters required to be discussed in accordance with the applicable requirements of the Public Company Accounting Oversight Board ("PCAOB") including Auditing Standard No. 1301 - Communications with Audit committees and the SEC; and
|
•
|
Received written disclosures and the letter from Deloitte & Touche LLP as required by applicable requirements of the PCAOB regarding Deloitte & Touche LLP's communications with the Audit Committee concerning independence and the Audit Committee further discussed with Deloitte & Touche LLP their independence. The Audit Committee also considered the status of pending litigation, taxation matters and other areas of oversight relating to the financial reporting and audit process that the committee determined appropriate.
|
|
|
|
|
|
|
Members of the Audit Committee of
|
|
|
|
Hydrofarm Holdings Group, Inc.
|
|
|
|
||
|
|
||
|
|
Mr. Richard D. Moss
|
|
|
|
Ms. Melisa Denis
|
|
|
|
Ms. Renah Persofsky
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
•
|
Review and approve, prior to the Company's entry into any such transactions, all transactions involving amounts equal to or greater than $120,000 in which the Company is or will be a participant, which would be reportable by the Company under Item 404 of Regulation S-K promulgated under the Securities Act as a result of any of the following persons having or expected to have a direct or indirect material interest (a "Related Person Transaction"):
|
○
|
executive officers of the Company;
|
○
|
members of the board of directors;
|
○
|
beneficial holders of more than 5% of the Company's securities;
|
○
|
immediate family members (as defined by Item 404 of Regulation S-K promulgated under the Securities Act) of or entities affiliated with any of the foregoing persons; and
|
○
|
any other persons whom the board of directors determines may be considered to be related persons as defined by Item 404 of Regulation S-K promulgated under the Securities Act.
|
•
|
Any request for a Related Person Transaction must first be presented to the Audit Committee for review, consideration and approval. In reviewing, considering, and approving or rejecting such transactions, the Audit Committee shall obtain, or shall consider all available information that the Audit Committee believes to be relevant to a review of the transaction prior to its approval including, but not limited to, the extent of the related person's interest in the transaction, and whether the transaction is on terms no less favorable to the Company than terms the Company could have generally obtained from an unaffiliated third party under the same or similar circumstances. Following such consideration, approval may be given by written consent of the Audit Committee. No Related Person Transaction shall be entered into prior to the completion of these procedures.
|
TABLE OF CONTENTS
•
|
The Audit Committee or the Chairperson of the Audit Committee, as the case may be, shall approve only those Related Person Transactions that are determined to be in, or not inconsistent with, the best interests of the Company and its stockholders. No member of the Audit Committee shall participate in any review, consideration or approval of any related person transaction with respect to which the member or any of his or her immediate family members has an interest.
|
•
|
The Audit Committee shall adopt any further policies and procedures relating to the approval of Related Person Transactions that it deems necessary or advisable from time to time.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
2024
|
|
|
2023
|
|
Audit fees:(1)
|
|
|
$1,723,939
|
|
|
$2,126,249
|
Audit related fees:
|
|
|
-
|
|
|
-
|
Tax fees:(2)
|
|
|
319,798
|
|
|
340,893
|
All other fees
|
|
|
-
|
|
|
-
|
Total
|
|
|
$2,043,737
|
|
|
$2,467,142
|
|
|
|
|
|
|
|
(1)
|
Audit fees include fees and related expenses for professional services rendered in connection with the annual audit of the Company's financial statements and the review of the Company's interim financial statements, as well as fees for services that generally only the independent registered public accounting firm can be reasonably expected to provide, including consents and review of registration statements filed with the SEC.
|
(2)
|
Tax fees include fees and other related expenses for U.S. federal and state tax compliance, foreign tax compliance, and tax consulting.
|
1.
|
Auditservices include audit work performed in the preparation of financial statements, as well as work that generally only an independent registered public accounting firm can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or reporting standards.
|
2.
|
Audit-Relatedservices include assurance and related services that are traditionally performed by an independent registered public accounting firm, such as due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements.
|
3.
|
Taxservices include all services performed by an independent registered public accounting firm's tax personnel except those services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice.
|
4.
|
Other services include services not captured in the other categories. The Company generally does not request such services from our independent registered public accounting firm.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS